Seeking Alpha covers Starpharma

11 August 2017

Online stock market insights and research publication Seeking Alpha covered Starpharma’s Phase 3 results for VivaGel® BV for the treatment of recurrent bacterial vaginosis and noted the “substantial upside” of the announcement.

To view the article, click here.

About Starpharma

This document contains Forward Looking Statements

For Further Information

© Starpharma Holdings Limited 2017